{
    "organizations": [],
    "uuid": "ba4da92c06c0ea60eefe7db79c5cc2c2bcea2954",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cerenis-therapeutics-holding-fy-op/brief-cerenis-therapeutics-holding-fy-operating-loss-of-6-6-million-euros-idUSFWN1PR17A",
    "ord_in_thread": 0,
    "title": "BRIEF-Cerenis Therapeutics Holding FY Operating Loss of 6.6 Million Euros‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Cerenis Therapeutics Holding Sa :\n* SOLID CASH POSITION OF €16.3 MILLION AT DECEMBER 31, 2017 ‍​\n* FY OPERATING LOSS EUR 6.6 MILLION VERSUS EUR 24.0 MILLION YEAR AGO\n* FY NET LOSS EUR 5.0 MILLION VERSUS EUR 24.9 MILLION YEAR AGO\n* RESULTS OF TANGO STUDY SHOULD NOW BE OBTAINED IN Q4 2018‍​ Source text: bit.ly/2nzuef5 Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-02T02:36:00.000+02:00",
    "crawled": "2018-02-02T12:38:47.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cerenis",
        "therapeutic",
        "holding",
        "sa",
        "solid",
        "cash",
        "position",
        "million",
        "december",
        "fy",
        "operating",
        "loss",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "year",
        "ago",
        "result",
        "tango",
        "study",
        "obtained",
        "q4",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}